Gemcitabine 00409-0182-25

Package NDC

00409-0182-25

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 22, 2011
Listing Expires: December 31, 2027
Application: NDA200795

Need to source Gemcitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Gemcitabine Hydrochloride	38 mg/mL

Drug Class

Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Packaging Options(1)

00409-0182-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0182-01) / 52.6 mL in 1 VIAL, SINGLE-DOSE

View →